13.02.2019 Views

FM JANUARY 2019 - digital edition

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

when catheters were the mainstay of<br />

interventional procedures, IRs currently<br />

employ a variety of devices and<br />

techniques to tackle complex anatomies<br />

like the brain. IR itself is getting further<br />

diversified into subspecialties focusing<br />

on areas like the brain or abdomen<br />

exclusively.<br />

IR, presently, allows procedures<br />

including angioplasty, endovascular<br />

aneurysm repair, embolisations,<br />

ablations, biliary intervention,<br />

placement of central venous catheters,<br />

nephrostomy, pleural aspiration and<br />

vertebroplasty. The list of indications<br />

is likely to expand with advances in<br />

technology.<br />

In situations where a patient is<br />

contraindicated for a surgical procedure<br />

due to a highly complicated condition,<br />

the intervention by an IR can often make<br />

a dramatic difference.<br />

Even though percutaneous<br />

interventions usually represent a safer<br />

approach compared with traditional<br />

surgical alternatives, IR procedures<br />

can lead to iatrogenic interventional<br />

complications. Inadvertent injury to<br />

blood vessels represents one of the<br />

most common among them. Such<br />

complications can range from minor to<br />

catastrophic.<br />

Biopsy to<br />

diagnose cancer<br />

• Angioplasty and stent<br />

insertion<br />

• Ascitic tap<br />

• Biliary drainage<br />

• Bursal injection<br />

• Carotid stenting<br />

• Carpal tunnel ultrasound<br />

and injection<br />

• Image-guided cervical<br />

nerve root sleeve<br />

corticosteroid injection<br />

• Image-guided liver biopsy<br />

• Image-guided lumbar<br />

epidural corticosteroid<br />

COMMON IR PROCEDURES<br />

Treatment of<br />

Primary Tumors<br />

injection<br />

• Image-guided lumbar<br />

nerve root sleeve injection<br />

• Nephrostomy<br />

• Pleural aspiration<br />

• Radiofrequency ablation<br />

• Radioembolisation<br />

• Cryoablation<br />

• Joint injection<br />

• Thyroid fine needle<br />

aspiration (FNA)<br />

• Inferior vena cava filters<br />

• Uterine fibroid<br />

embolisation<br />

Treatment of<br />

symptoms such as<br />

pain, infection of<br />

swelling caused from<br />

spread of cancer<br />

Placement of devices<br />

such as catheters,<br />

feeding tubes and<br />

ports to deliver<br />

medications<br />

• Varicose vein ablation<br />

• Vascular closure devices<br />

• Venous access<br />

• Vertebroplasty<br />

• Subarachnoid<br />

hemorrhage vasospasm<br />

endovascular treatment<br />

• Selective internal radiation<br />

therapy (SIRT)<br />

• Spinal cord embolisation<br />

(AVM/DAVF)<br />

• Transarterial<br />

chemoembolisation (TACE)<br />

ABLATING<br />

UNRESECTABLE<br />

TUMOURS<br />

RFA is more effective than any<br />

other modality for<br />

unresectable liver cancer<br />

Radio Frequency Ablation (RFA)<br />

has been found highly useful in<br />

liver tumours. With the help of this<br />

outpatient procedure, clinicians can<br />

change the inoperable status of a<br />

patient to operable in many cases.<br />

Its effectiveness, however, greatly<br />

depends upon the size of the growth.<br />

“The size of the liver tumour is an<br />

important determining criterion as far<br />

the outcome of RFA is concerned,’’<br />

said Dr S Kalpana, Professor at Barnard<br />

Institute of Radiology, Chennai, making<br />

a presentation titled “RFA for Liver<br />

Tumours” at the recent TNPY IRIA,<br />

at Chennai. According to her, RFA is<br />

a safe, cost-effective and promising<br />

option for recurrent, unresectable<br />

hepatocellular carcinoma (HCC). The<br />

procedure is more effective than other<br />

modalities in HCC.<br />

Microwave tumour ablation<br />

provides a potentially curative<br />

treatment option for various<br />

neoplasms. Tried and tested for over<br />

15 years, the safety and efficacy of<br />

colorectal liver metastasis (CRLM)<br />

ablation has been demonstrated in<br />

52 / FUTURE MEDICINE / <strong>JANUARY</strong> <strong>2019</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!